Patients taking blood thinners (aspirin, warfarin, or certain anticoagulants) experience prolonged bleeding into tissue, resulting in larger or darker bruises
Regulatory Status and Research Context AOD-9604 is not FDA-approved for any therapeutic indication
These figures represent typical ranges based on current market conditions and may fluctuate based on supply, demand, and regulatory changes
PMID: 28143741 Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis Bo Xiao, Zhigang Xu, Emilie Viennois, Yuchen Zhang, Zhan Zhang, Mingzhen Zhang, Moon Kwon Han, Yuejun Kang, and Didier Merlin ~ Gastroenterology